![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tomlinson B.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.18, Iss.9, 2001-01, pp. : 665-683
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lipid-Lowering Treatment in Coronary Artery Disease: How Low Should Cholesterol Go?
By Jones P.H.
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New prospects for lipid-lowering drugs
By Thompson G.R. Naoumova R.P.
Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Willingness-to-pay a better measure to value drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 609, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Why do Americans pay more for drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 601, 2010-01 ,pp. :